403731-47-5

Basic information

• Product Name: 5-O-benzyl-3-O-(2,6-di-O-benzyl-α-D-glucopyranosyl)uridine
• Synonyms: 5-O-benzyl-3-O-(2,6-di-O-benzyl-α-D-glucopyranosyl)uridine
• CAS NO: 403731-47-5
• Molecular Weight: 676.72
• Mol File: 403731-47-5.mol

Chemical Properties

• CAS DataBase Reference: 5-O-benzyl-3-O-(2,6-di-O-benzyl-α-D-glucopyranosyl)uridine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-O-benzyl-3-O-(2,6-di-O-benzyl-α-D-glucopyranosyl)uridine(403731-47-5)
• EPA Substance Registry System: 5-O-benzyl-3-O-(2,6-di-O-benzyl-α-D-glucopyranosyl)uridine(403731-47-5)

Safety Data

• Hazardous Substances Data: 403731-47-5(Hazardous Substances Data)

Upstream product

• 31504-85-5 3,5-O-benzylidene-1,2-O-isopropylidene-α-D-xylofuranose 
• 264230-04-8 3,4-di-O-acetyl-2,6-di-O-benzyl-D-glucopyranosyl dimethyl phosphite 
• 178319-07-8 allyl 3,4-di-O-acetyl-2,6-di-O-benzyl-α-D-glucopyranoside 
• 169822-03-1 allyl 2,6-di-O-benzyl-α-D-glucopyranoside 
• 20031-21-4 1,2-O-isopropylidene-α-D-xylose 
• 1125-88-8 benzaldehyde dimethyl acetal 
• 2592-42-9 5-O-benzyl-1,2-O-isopropylidene-α-D-ribofuranose 
• 34311-63-2 5-O-benzyl-3-oxo-1,2-O-isopropylidene-α-D-xylofuranose 
• 23202-83-7 5-benzyl-1,2-O-isopropylidene-α-D-xylofuranose 
• 264230-05-9 3-O-(3',4'-di-O-acetyl-2',6'-di-O-benzyl-α-D-glucopyranosyl)-5-O-benzyl-1,2-O-isopropylidene-α-D-ribofuranoside 
• 197644-83-0 1,2-di-O-acetyl-3-O-(3',4'-di-O-acetyl-2',6'-di-O-benzyl-α-D-glucopyranosyl)-5-O-benzyl-α/β-D-ribofuranoside 
• 403731-46-4 2'-O-acetyl-5'-O-benzyl-3'-O-(3,4-di-O-acetyl-2,6-di-O-benzyl-α-D-glucopyranosyl)uridine 

Relevant articles and documents

Total synthesis of nucleobase-modified adenophostin A mimics

The adenophostins exhibit approximately 10-100 times higher receptor binding and Ca2+ mobilising potencies in comparison with the natural second messenger D-myo-inositol 1,4,5-trisphosphate [InS(1,4,5)P3]. Despite many synthetic atte

Convergent synthesis of adenophostin A analogues via a base replacement strategy

The first totally synthetic base-modified analogues of the natural product and potent D-myo-inositol 1,4,5-trisphosphate receptor agonist adenophostin A were efficiently synthesised from D-xylose and D-glucose using methodology employing base and surrogate base addition to a common disaccharide intermediate.